Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001723464-26-000028
Filing Date
2026-05-14
Accepted
2026-05-14 13:06:50
Documents
8
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 REPORT bhsc_6k.htm 6-K 14382
2 UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS bhsc_ex991.htm EX-99.1 281381
3 MANAGEMENT'S DISCUSSION AND ANALYSIS bhsc_ex992.htm EX-99.2 106279
4 CERTIFICATION OF CEO bhsc_ex993.htm EX-99.3 11616
5 CERTIFICATION OF CFO bhsc_ex994.htm EX-99.4 12370
6 bhscex991_1.jpg GRAPHIC 5629
7 bhscex992_1.jpg GRAPHIC 10586
8 bhscex992_2.jpg GRAPHIC 11026
  Complete submission text file 0001723464-26-000028.txt   465135
Mailing Address 1140 - 625 HOWE STREET VANCOUVER A1 V6C 2T6
Business Address 1140 - 625 HOWE STREET VANCOUVER A1 V6C 2T6 6046221186
BIOHARVEST SCIENCES INC. (Filer) CIK: 0001723464 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42389 | Film No.: 26977411
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)